Drawing for AMGEN BIOSIMILARS

USPTO serial 86763408

AMGEN BIOSIMILARS

Reviewed by CopyMark Law Group

Reg. 5926793Status 710
Filing date
Status date
Registration date
Dec 3, 2019
Examiner
TOY, JOSHUA SPENCER JOLL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with AMGEN BIOSIMILARS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.One Amgen Center DriveTrademark Operations - MS-28-5AThousand Oaks, CA 91320-1799

Goods and services

ClassDescriptionStatusFirst use
041Providing online publications in the nature of brochures and newsletters in the fields of pharmaceuticals, biosimilars, medicines and health; arranging and conducting classes, seminars and workshops in the fields of pharmaceuticals, biosimilars, medicines and health; educational services, namely, programs about pharmaceuticals, biosimilars, medicines and health accessible by means of audio, video, web-based applications, mobile phone applications, and computer networks; educational services, namely, conducting programs in the fields of pharmaceuticals, biosimilars, medicines and healthSECTION 8 - CANCELLEDJan 12, 2015
042Research and development of pharmaceutical preparations and biosimilars; research and development in the pharmaceutical and biotechnology fields; medical and scientific research information in the fields of pharmaceutical preparations, biosimilars and clinical trials; providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals preparations and biosimilars; providing websites featuring medical and scientific research information about pharmaceuticals preparations and biosimilars; support services in the nature of a helpdesk, namely, providing medical and health information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals preparations and biosimilars; providing online non-downloadable computer software used to access, manage, update and display electronic databases in the fields of pharmaceutical preparations and biosimilarsSECTION 8 - CANCELLEDJan 12, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 19, 2026C8..CANCELLED SEC. 8 (6-YR)—
Feb 25, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 25, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 25, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 3, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 29, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 29, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 29, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 29, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 29, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 3, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 29, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 28, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 17, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 9, 2019IUAFUSE AMENDMENT FILED—
Oct 9, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 3, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 2, 2019EX5GSOU EXTENSION 5 GRANTED—
Apr 2, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 28, 2019EXT5SOU EXTENSION 5 FILED—
Mar 28, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 5, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 3, 2018EX4GSOU EXTENSION 4 GRANTED—
Oct 3, 2018EXT4SOU EXTENSION 4 FILED—
Oct 3, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 31, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 29, 2018EX3GSOU EXTENSION 3 GRANTED—
Mar 29, 2018EXT3SOU EXTENSION 3 FILED—
Mar 29, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 13, 2017EX2GSOU EXTENSION 2 GRANTED—
Sep 13, 2017EXT2SOU EXTENSION 2 FILED—
Sep 13, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 25, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 23, 2017EX1GSOU EXTENSION 1 GRANTED—
Mar 23, 2017EXT1SOU EXTENSION 1 FILED—
Mar 23, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 11, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 8, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 7, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2016DOCKASSIGNED TO EXAMINER—
Sep 26, 2015MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 25, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance